54 results about "Epimedium brevicornum" patented technology

The invention discloses an application and product of icariin in the drug to treat senile dementia, which is characterized by the following: extracting icariin from berbere epimedium plant as flavonol compound; adopting icariin as raw material to prepare the monoclinic agent with simple technique and low cost; fitting for treating senile dementia with obvious effect and little side effect.

The invention belongs to the technical field of traditional Chinese medicines, in particular discloses a Chinese medicinal composition for treating necrospermia, asthenospermia oligospermia, or aspermatism, which comprises the following raw material medicaments in part by weight: 10 to 20 parts of epimedium brevicornum, 10 to 20 parts of medicinal indianmulberry root, 10 to 20 parts of desertliving cistanche, 10 to 20 parts of south dodder seed, 10 to 20 parts of siberian solomonseal rhizome, 10 to 20 parts of Chinese angelica, 7 to 13 parts of common curculigo rhizome, 8 to 16 parts of Chinese thorowax root, 8 to 16 parts of large-headed atractylodes rhizome, 14 to 26 parts of astragalus, 14 to 26 parts of radix rehmanniae praeparata, 14 to 26 parts of dioscorea root, 3 to 8 parts of liquorice root, 5 to 13 parts of glossy privet fruit, 10 to 20 parts of plantain seed, 10 to 20 parts of palmleaf raspberry fruit, 20 to 40 parts of root of red-rooted salvia, 8 to 16 parts of eucommia bark, 7 to 13 parts of baicalin, 3 to 8 parts of salivia chinensis, 6 to 13 parts of Indian buead and 6 to 14 parts of oriental waterplantain rhizome. The Chinese medicinal composition has the effects of warming and invigorating kidney yang with tonifying qi and invigorating blood circulation and supplementing essence and replenishing marrow, and has the advantages of simple preparation, convenient administration, good curative effect and no toxic or side effect.

The invention discloses a sulfating modification method of epimedium polysaccharide, belonging to the technical field of structural improvement. The method comprises the steps of extracting and purifying the epimedium polysaccharide, using chlorosulfonic acid-pyridine method for sulfating molecular modification, setting 9 modification conditions according to L9(3<4>) orthogonal test based on 3 factors of the reaction temperature, the reagent proportion and the reaction time and respectively modifying to obtain 9 epimedium polysaccharides. The optimum modification conditions are determined that the reaction temperature is 80 DEG C, the proportion of chlorosulfonic acid and pyridine is 1:8 and the reaction time is 1h through systematically comparing the immune enhancing activity and the antiviral activity of the 9 sulfated epimedium polysaccharides. The obtained sulfated epimedium polysaccharide has the highest sugar content and the strongest activity. The sulfating modification method of epimedium polysaccharide can obviously enhance the immune enhancing activity and the antiviral activity of the epimedium polysaccharide.

The invention discloses an oral combination of Chinese medicines in treating gout, belonging to the Chinese medicine field. The material medicine of the efficient components of the medicine combination are as follow weights: 20g of astragalus membranaceus, 15g of radix aconiti preparata, 8g of panax, 10g of rhizoma typhonii, 10g of prepared rhizoma pinelliae, 10g of notopterygium incisum, 10g of radix paeoniae alba, 10g of epimedium brevicornum, 10g of rhizome dioscoreae hypoglaucae, 10g of angelica, 9g of tuckahoe, 6g of saposhnikovia divaricata, 3g of asarum, 6g of angelica pubescens, 6g of cinnamon, 6g of roast glycyrrhiza uralensis, 5g of ligusticum chuanxiong, 10g of spatholobus suberectus and 10g of sinomenium acutum. The medicine should be taken by being decocted with water, one potion per day, every potion should be taken in three times, in a 20-day treatment period. After the combination of the medicines above in the invention, the medicine effects work together with the effects of dispeling wind, eliminating dampness, reducing swelling and easing pain. The oral combination of Chinese medicines is capable of adjusting purin metabolize, restraining the production of uric acid and building up autoimmunization.

The invention provides a small complex prescription of a traditional Chinese medicine for preventing and treating glucocorticoids-induced osteoporosis, and a preparation method thereof. The complex prescription of the traditional Chinese medicine is composed of epimedium brevicornum maxim and ligustrum lucidum ait. Animal experiments demonstrate that the small complex prescription of the traditional Chinese medicine can effectively reduce the content of serum tartrate-resistant acid phosphatase and alkaline phosphatase, increase serum osteocalcin and the calcium content of bone tissues, and effectively improve pathological changes of the bone tissues, in a hormone-intervened wistar osteoporosis model. The small complex prescription of the traditional Chinese medicine is based on neutrally supplementing yin and yang in kidney with tonifying kidney and strengthening bones as treatment principles, can effectively prevent and alleviate adverse effects of osteoporosis caused by taking glucocorticoids for a long time, provide effective preparations for preventing and treating osteoporosis to other varieties of patients suffering from osteoporosis, and has good development and application prospects.

The invention mainly relates to a cancellous bone-benefiting prescription for treating osteoporosis and a preparation technology of the cancellous bone-benefiting prescription. The cancellous bone-benefiting prescription comprises the following active ingredients in parts by weight: 25-35 parts of astragalus membranaceus, 13-17 parts of codonopsis pilosula, 10-14 parts of angelica sinensis, 14-16 parts of eucommia ulmoides, 14-16 parts of epimedium brevicornum maxim, 9-11 parts of rhizoma corydalis, 9-11 parts of myrrh and 16-20 parts of caulis spatholobi. The cancellous bone-benefiting prescription has the effects of tonifying kidney and spleen, nourishing the blood and promoting blood circulation, strengthening tendons and bones, and activating meridians to stop pain, can effectively treat primary and secondary osteoporosis, and has significant curative effects on back and loin aching, tiredness and dull pain, waist tenesmus, limbs lassitude and numbness, tiredness and weakness, dizziness, legs and feet cramp and the like due to spleen and kidney deficiency and blood stasis. The preparation technology is simple, and the production cost is low. In the preparation technology, one half of astragalus membranaceus and one half of codonopsis pilosula are decocted with the epimedium brevicornum maxim, the rhizoma corydalis and the caulis spatholobi, the other half of astragalus membranaceus and the other half of codonopsis pilosula as well as the angelica sinensis, the eucommia ulmoides and the myrrh are made into powder. Therefore, the effects of the prepared cancellous bone-benefiting prescription are significant. The cancellous bone-benefiting prescription and the preparation technology thereof are suitable for popularization and application.

The invention relates to a physical fatigue releasing wine and a preparation method thereof. The preparation method comprises: carrying out drying, crushing and screening on eleutherococcus senticosus, Chinese wolfberry, epimedium brevicornu, and panax quiquefolium, adjusting the Baijiu to achieve the alcoholicity of 30-36% with purified water, dipping the prepared herb crude powder into the prepared Baijiu with the alcoholicity of 30-36% for 48 g, percolating at a speed of 1-3 ml / min / Kg, collecting 900 ml of the percolate, standing for 24 h, taking the supernatant, adding 35-45 g of white granulated sugar to dissolve, blending into 1000 ml of the wine liquid with an alcoholicity of 30-36% with Baijiu, and filtering so as to obtain the finished product. According to the present invention, the prepared wine has the physical fatigue releasing function, and the preparation method is simple.

A pharmaceutical composition for the treatment of rheumatism and a method of preparing it are provided. The composition consists of an alcoholic extract of 1-4 parts by weight Tripterygium hypoglaucum (Levl.) Hutch.; 1-4 parts by weight Epimedium brevicornum Maxim.; 1-4 parts by weight Lycium barbarum L.; and 1-4 parts by weight Cuscuta chinensis Lam., or Cuscuta australis R. Br. The composition has substantial therapeutic efficacy, with mild side effects, and is easy to administer.

A pharmaceutical composition for the treatment of rheumatism and a method of preparing it are provided. The composition consists of an alcoholic extract of 1-4 parts by weight Tripterygium hypoglaucum (Levl.) Hutch.; 1-4 parts by weight Epimedium brevicornum Maxim.; 1-4 parts by weight Lycium barbarum L.; and 1-4 parts by weight Cuscuta chinensis Lam., or Cuscuta australis R. Br. The composition has substantial therapeutic efficacy, with mild side effects, and is easy to administer.

The invention belongs to the technical field of Chinese medicaments, and in particular discloses a Chinese medicinal composition for treating impotence, which comprises the following raw material medicaments in part by weight: 10 to 14 parts of Chinese thorowax root, 10 to 14 parts of White paeony root, 10 to 14 parts of fructus aurantii immaturus, 10 to 14 parts of honey-fried liquoric root, 18 to 22 parts of tribulus root, 10 to 14 parts of thinleaf milkwort root-bark, 10 to 14 parts of grassleaf sweelflag rhizome, 16 to 20 parts of desertliving cistanche, 13 to 17 parts of south dodder seed, 8 to 12 parts of tortoise plastron, 10 to 14 parts of medlar, 7 to 11 parts of Chinese angelica, 8 to 12 parts of ant powder, 5 to 9 parts of siberian solomonseal rhizome, 4 to 8 parts of medicinal indianmulberry root, 18 to 22 parts of root of red-rooted salvia, 6 to 10 parts of epimedium brevicornum and 4 to 8 parts of cortex moutan. The medicament of the invention has the effects of soothing the liver and regulating vital energy, promoting blood circulation by removing blood stasis, tonifying the liver and kidney, regulating the heart blood, coordinating the function of three viscera and strengthening yang, invigorating pulse and treating impotence, and has the advantages of simple preparation, simple and convenient administration, no toxic or side effect, definite curative effect and stable long-term curative effect.

The invention discloses a medicine for treating otitis media. The medicine comprises 2-6g of Oldenlandia diffusa, a centipede, 3-8g of snake slough, 2-6g of Bat Dung, 10-20g of fructus psoraleae, 3-8g of kelp, 5-10g of cotton seed, 4-8g of herba epimedii, 10-20g of honeysuckle, 5-12g of fructus forsythiae and 10-24g of glycerin. The medicine can be daubed into the auditory meatus for treatment. The medicine has a good effect of treating the otitis media, an external application method is adopted, excretion of liver and kidney can be reduced, and the burden of organs in the body can be reduced.

The invention relates to total flavonoid extract of Epimedium brevicornum, a preparation method and an active application to sleep improvement, and belongs to the technical field of pharmaceutical. Dry leaves of the Epimedium brevicornum are taken, chopped and decocted with water, water adding amount, extraction time and extraction times are controlled, extract liquids are mixed and filtered whilethe liquids are still hot, a filtrate is concentrated, a concentrate is added to pre-treated macroporous adsorption resin column, an eluate is collected, ethanol with concentration of 30%-95% is taken as a solvent, coarse extract is added to 4-12 times by weight of the solvent and stirred for 10-40 min, the mixed solution is filtered, a filtrate is concentrated into thick paste in a water bath and subjected to reduced-pressure drying, and the total flavonoid extract of the Epimedium brevicornum is prepared. The method is applicable to industrial production and preparation of the total flavonoid extract of the Epimedium brevicornum, the application range of the total flavonoid extract in the field of sleep improvement drugs and healthcare food is expanded, and broader idea is provided forcomprehensive development and utilization of the Epimedium brevicornum medicinal materials.

The invention discloses a traditional Chinese medicine preparation for postmenopausal osteoporosis. Raw materials of the traditional Chinese medicine preparation comprise eucommia ulmoides, prepared rehmannia roots, epimedium brevicornum maxim, drynaria fortunei, cnidium monnieri, astragalus membranaceus, cuscuta chinensis lam, fructus lycii, angelica sinensis, paeonia lactiflora pallas, cornus officinalis, salvia miltiorrhiza bunge, peach kernels, carthamus tinctorius and achyranthes bidentata. According to different characteristics of traditional Chinese medicines, the raw materials are washed, diced and preprocessed and then prepared proportionally. The traditional Chinese medicine preparation is prepared through a special method and has the effects of tonifying the kidneys, growing bones, benefiting the liver, tonifying the spleen and promoting blood circulation to remove meridian obstruction. The combining and preparation method of the traditional Chinese medicine preparation is unique, and clinical verification shows that the traditional Chinese medicine preparation has a significant treatment effect, a short treatment period and low price, has no untoward effects or any toxic or side effects and has broad market application prospects.

The invention discloses a cistanche extract composition with the effect of obviously relieving the physical fatigue and a preparation method thereof. A traditional Chinese medicine extract is prepared from 90 to 150 parts of cistanche tubulosa wight extracts, 100 to 170 parts of eleutherococcus senticosus extracts and 80 to 110 parts of epimedium brevicornum extracts, wherein the content of phenylethanoid glycosides in the cistanche tubulosa wight extracts is greater than 40.0 percent; the content of eleutheroside B1 and C in the eleutherococcus senticosus extracts is greater than 0.8 percent; the icariin in the epimedium brevicornum extracts is greater than 8.0 percent. Functional experiments prove that the physical fatigue relieving efficiency of the composition prepared by compounding the eleutherococcus senticosus extracts with the eleutheroside B1 and C reaching the standard, the cistanche tubulosa wight extracts and the epimedium brevicornum extracts can be obviously improved, and the action is even better than that of the eleutheroside B and E; the mouse loading swimming time can be obviously prolonged; the mouse hepatic glycogen storage quantity is increased; the serum urea level after mouse movement is reduced; the mouse fatigue is relieved; the effect is better than that of the single use of the cistanche tubulosa wight extracts.

The invention relates to a Chinese medicament for preventing and curing leucemia, comprising: 5-10 wt.% of lycii fructus, 9-15 wt.% of viscum album, 6-10 wt.% of suberect spatholobus stem, 4-8 wt.% of epimedium brevicornum maxim, 8-15 wt.% of beautiful millettia root, 5-10 wt.% of root of philippine flemingia, 8-10 wt.% of cherokee rose fruit, 5-10 wt.% of fructus ligustri, 1-3 wt.% of cuscuta campestris, 6-15 wt.% of cynomorium songaricum, 5-15 wt.% of chaste tree, 8-15 wt.% of wild pepper, and 4-8 wt.% of Chinese ephedra. The raw materials are weighted according the weight percentage and put into a pot for decoction with water weight of which is 4 times of that of the raw materials (strong heating fire firstly, and then slow fire); the fire is stopped until the weight of the left water is only one time of that of the raw materials; residues are removed to obtain the aqueous solution for curing leucemia, effective rate of which is 90% and ineffective rate of which is 10%.

The invention discloses a pharmaceutical composition for the treatment of female infertility as well as a preparation method and a quality control method thereof, the composition is any one of pharmaceutically acceptable preparations such as pellet, granule, tablet, syrup, mixture, oral liquid, dripping pill, capsule and injection prepared by epimedium brevicornum, sealwort, teasel root, astragalus root, rhizome cyperi and licorice. The quality control method thereof comprises the steps of: thin-layer identification of the epimedium brevicornum, sealwort, radix dipsaci, licorice, licorice and astragalus root; HPLC content measurement of the epimedium brevicornum, radix dipsaci and licorice; measurement of total contents of flavone and saponin. The pharmacodynamical experiments include: in vivo experiment, in vitro cell experiment and clinical experiment. The experiments demonstrate that: the inventive pharmaceutical composition has the effects of warming kidney, replenishing sperm and conditioning emmenia, and the pharmaceutical composition can be used for the treatment of the female infertility.

The invention provides a traditional Chinese medicament for treating endometrial thickening with ovarian cysts. The traditional Chinese medicament mainly comprises pseudo-ginseng, cirsium japonicum, cirsium setosum, safflower, fried peach kernels, radix paeoniae rubra, curcuma aromatica, roasted ginger, wild chrysanthemum, corydalis bungeana, indigowoad root, pericarpium citri reticulatae, Chinese thorowax root, roasted rhizoma atractylodis macrocephalae, astragalus membranaceus, polygala tenuifolia, epimedium brevicornum, leonurus japonicas, white peony root, colla corii asini and daemonorops draco. The medicines are weighed according to the ratio, and then screened through a 100-200-mesh sieve, so that the medicament is obtained. On the basis of the traditional Chinese medicine theory of the China and for the pathogenesis of the endometrial thickening with ovarian cysts, Chinese herbal medicine components are carefully selected and scientifically processed to be prepared into the medicament, and the medicament has the efficacy of quick action, high safety, no toxicity, short treatment course, low cost, treatment of both symptoms and root causes, beautifying, young keeping and life prolonging.

The invention discloses a plant flavonoid synthesis regulation gene and its application. CDNA obtained through the inverse transcription of the total RNA of Epimedium brevicornum Maxim blades is treated as a template and undergoes PCR to obtain a 233bp fragment, the 233bp fragment has a very high homology with flavonoid related R2R3-MYB gene, a full-length cDNA sequence is obtained through an RACE technology and is named EsMYBA1 gene, and the sequence of the EsMYBA1 gene is represented by SEQIDNO.1. The EsMYBA1 gene codes an R2R3-MYB transcription factor which has an about 50% homology with other MYB regulation genes for controlling the flavonoid synthesis approaches, and the improvement of the expression level of the EsMYBA1 gene through a genetic engineering technology promotes the synthesis and the accumulation of anthocyanidin.

The invention discloses a traditional Chinese medicine composition for treating osteoporosis and a preparing method of the traditional Chinese medicine composition. A recipe of medicine for treating osteoporosis comprises the following ingredients in parts by weight: 6 to 10 parts of resina draconis, 5 to 10 parts of liquorice, 8 to 12 parts of psoralea corylifolia, 4 to 6 parts of davallia mariesii, 4 to 6 parts of myrrh, 3 to 5 parts of epimedium brevicornum maxim, 3 to 5 parts of peach seeds, 5 to 8 parts of eucommia ulmoides, 4 to 6 parts of radix dipsaci, 3 to 5 parts of cynanchum paniculatum. According to the preparing method of the medicine for treating osteoporosis, the traditional Chinese medicine composition is subjected to superfine pulverization, so that active ingredients of the medicine are sufficiently released. The used traditional Chinese medicine composition for treating osteoporosis has low cost and can be used for a long time; by the preparing method using superfine pulverization, the utilization rate of the traditional Chinese medicine composition can be improved; and the obvious curative effect is achieved on osteoporosis of old and middle-aged people and osteoporosis of women after menostasia.

The invention mainly relates to a cancellous bone-invigorating formula for treating osteoporosis and a preparation technology thereof. The formula comprises the following raw materials by weight: 12-18 parts of radix rehmanniae praeparata, 13-17 parts of cornus officinalis, 10-14 parts of angelica sinensis, 14-16 parts of epimedium brevicornum maxim, 10-14 parts of semen cuscutae, 10-14 parts of medlar, 11-13 parts of rhizoma atractylodis macrocephalae and 11-13 parts of lumbricus. The cancellous bone-invigorating formula can treat the primary and secondary osteoporosis and osteomalacia effectively, takes significant curative effects on symptoms such as back, waist or whole body aching and tired, limb weakness, legs and feet cramp, deadlimb, dysphoria and irritability, palpitation and insomnia, sweating, a reddened tongue, yellowish coated tongue, a yellowish coatedtongue with crack and thready rapid pulse and the like due to deficiency of kidney-yin and blood stasis, and achieves remarkable effects of preventing bone mineral density from being reduced, reducing the bone turnover, and improving the balanced capacity. According to the invention, the preparation technology is simple, the production cost is low, and the curative effect of the drug prepared according to the formula is remarkable. Therefore, the formula and the preparation technology thereof are suitable for popularization and application.

The invention discloses a Chinese medicinal composition for treating bronchial asthma and a preparation method thereof. The Chinese medicinal composition comprises the following raw material medicaments in part by weight: 5 to 20 parts of pungent oleaster leaf, 4 to 18 parts of epimedium brevicornum and 2 to 12 parts of Chinese magnoliavine fruit. Capsules, tablets, granules, gels, slow-release formulations, oral liquid or pills are prepared by extracting pungent oleaster leaf, the epimedium brevicornum and the Chinese magnoliavine fruit through a conventional process method and adding pharmaceutically-acceptable auxiliary materials into the extract. The Chinese medicinal composition has the excellent effects of relieving asthma and stopping cough and reinvigorating and consolidating the constitution.

This invention discloses a medicinal wine, which comprises: Polygonum multiflorum 0.05-0.2 wt.%, Angelica sinensis 0.05-0.l2 wt.%, Iycium barbarum 0.1-0.5 wt.%, Ligustrum lucidum 0.1-0.5 wt.%, Dimocarpus longan 0.1-0.5 wt.%, Rehmannia glutinosa 0.1-0.5 wt.%, Epimedium brevicornum 0.1-0.5 wt.%, Phaseolus radiatus 0.1-0.5 wt.%, and wine 90-95 wt.%. The medicinal wine is prepared by: steaming Ligustrum lucidum, washing Rehmannia glutinosa and drying, removing root hair of Epimedium brevicornum, washing Phaseolus radiatus, Polygonum multiflorum and Angelica sinensis and drying, pulverizing the above medicines, filling into a cloth bag, fastening, filling wine into a porcelain bottle, adding the medicine bag into the porcelain bottle, sealing, and soaking for 1 month. The medicinal wine can improve human immunity, and has such advantages as convenient raw materials, low raw material usage amounts, and obvious effect.

The invention discloses a breeding method of andrias davidianus in a simulated ecological mode. The breeding method comprises the steps that a simulated ecological pool is built to conduct artificial breeding on the andrias davidianus; a breeding region with a high-quality environment is specially provided for breeding of the andrias davidianus in the simulated ecological pool, and the light intensity range of the breeding region is controlled within 50-300 Lux; a traditional Chinese medicine hanging bag is arranged on the water inlet of the breeding region, and the traditional Chinese medicine comprises eucommia ulmoides, radix polygoni multiflori and epimedium brevicornum maxim; the breeding region is not additionally covered with a sunshade net in the breeding process. The traditional Chinese medicine with the ratio of the eucommia ulmoides, the radix polygoni multiflori and the epimedium brevicornum maxim being 3:1:1 is adopted to conduct hanging bag breeding, accordingly the spawning rate, fertilization rate and hatching rate of parent andrias davidianus are improved by 10-20%, and the traditional Chinese medicine effectively promotes synchronization of male and female and is green and non-polluting and harmless to environment; the light intensity range of the breeding place is controlled within 50-300 Lux, and the gonad development of the andrias davidianus can be improved.

The invention provides a traditional Chinese medicine composition for treating female infertility, which is prepared from morinda officinalis, eucommia ulmoides, fructus psoraleae, semen cuscutae, ligustrum lucidum ait, fructus lycii, rubus idaeus, schisandra chinensis, cistanche, epimedium brevicornum maxim, tortoise-plastron glue, deer-horn glue, loofah sponge, lumbricus, rhizoma atractylodis macrocephalae, radix bupleuri and liquorice. The main cause of infertility is deficiency of the kidney, and as the kidney is the root of congenital constitution and the source of reproduction, and the spleen and the kidney are nourished mutually. Thus, to tonify the kidney supplemented by liver regulating and spleen tonifying is a method for treating the infertility. As long as the traditional Chinese medicines nourish the kidney to replenish essence, tonify the spleen and regulate the liver, and the functions of the liver, the spleen and the kidney coordinates, the uterus can achieve fertilization.

The invention discloses a preparation process for a yang strengthening medicinal wine. The process includes a material selection step: by mass, selecting 10-15 parts of Cynomorium songaricum, 20-30 parts of Epimedium brevicornu, 15-25 parts of Cistanche deserticola, 8-15 parts of Curculigo orchioides, 20-30 parts of Chinese wolfberry, 8-12 parts of Aconitum carmichaeli Debx, 9-15 parts of cinnamon, 10-20 parts of Morinda officinalis, 20-30 parts of Cuscuta chinensis, 15-20 parts of pickled Abelmoschus esculentus tender fruit, 5-10 parts of Chinese angelica, 10-30 parts of Chinese yam, 10-20 parts of Schisandra chinensis, 10-15 parts of Plantain Seed, 20-30 parts of walnut, 20-30 parts of red dates, and 50-100 parts of polished rice. The yang strengthening medicinal wine designed by the invention has significant yang strengthening effect, also can play a body building role, can be used as an alcoholic beverage, has significant effect, and integrates the treatment and health care effects. According to the invention, the Abelmoschus esculentus tender fruit is subjected to deep processing successfully, the ground fine powder of Abelmoschus esculentus grains is also added, the rich nutritional ingredients of the two substances do not lose, and can have the efficacy of enhancing human memory and energy. At the same time, during drinking, the medicinal wine has excellent taste and mellow flavor, also the nutrition of the medicinal wine can be fully released, and the human body absorption rate is greatly improved.

The invention relates to a Chinese medicament for improving in vitro fertilization and embryo transfer (IVF-ET) post-implantation dysfunction. The Chinese medicament consists of the following medicinal materials in part by weight: 15 to 25 parts of rehmannia root, 8 to 12 parts of roasted ligustrum lucidum ait, 15 to 25 parts of roasted cuscuta chinensis, 8 to 12 parts of cibotium barometz, 8 to 12 parts of epimedium brevicornum maxim, 8 to 12 parts of donkey-hide gelatin, 8 to 12 parts of amomum villosum, 8 to 12 parts of roasted cornus officinalis, 8 to 12 parts of Chinese yam, 8 to 12 parts of eclipta prostrata, 8 to 12 parts of roasted eucommia ulmoides oliv, 8 to 12 parts of dipsacus asperoides, 15 to 25 parts of mistletoe, 8 to 12 parts of prepared tuber fleeceflower root, and 8 to 12 parts of liquorice. Experiments prove that the Chinese medicament can safely and effectively improve the IVF-ET post-implantation dysfunction.

The invention discloses a traditional Chinese medicine preparation for facilitating lumbar disc herniation rehabilitation. The traditional Chinese medicine preparation for facilitating lumbar disc herniation rehabilitation is made by pimpinella thellungiana, notopterygium incisum, cyathula officinalis, fluorite, fennel, dried ginger, common clubmoss herbs, radix clematidis, atractylodes lancea, divaricate saposhnikovia roots, cortex acanthopanacis, radix angelicae pubescentis, turmeric, psoralea corylifolia, trogopterus dung, frankincense, myrrh, radix paeoniae alba, rhizoma corydalis, cassia twigs, aconitum carmichaelii, epimedium brevicornum maxim, himalayan teasel roots, prepared rehmannia roots and fenugreek according to a certain weight ratio. The traditional Chinese medicine preparation for facilitating lumbar disc herniation rehabilitation has the effects of removing blood stasis, removing meridian obstruction, easing joint movement and warming and nourishing the liver and kidneys and can effectively treat lumbar disc herniation.

The present invention discloses a blood lipid regulating marine functional health-care beverage which is obtained by scientifically matching raw materials of astaxanthin and Chinese herbal medicines. The formula is optimized as follows: chitosan 10-20 parts, astaxanthin 10-20 parts, haws 15-20 parts, sophora japonica flowers 10-15 parts, polygonatum odoratum 10-20 parts, alisma plantago-aquatica 5-10 parts, semen cassiae 10-15 parts, cordyceps sinensis 5-8 parts, epimedium brevicornu 3-5 parts, angelica sinensis 3-5 parts, rosa laevigata fruits 4-6 parts, dioscorea hypoglauca rhizomes 2-3 parts, licorice 3-5 parts and stevia rebaudiana 3-5 parts. And then the beverage is prepared according to the processes of extracting, mixing, blending, filling and sterilizing. The advantages of the health-care beverage lie in that the synergistic effects among the chitosan, astaxanthin and Chinese herbal medicines have significant efficacies of regulating blood lipids, tonifying and replenishing qi, supporting healthy energy, preventing fatigue, prolonging life, etc., and the health-care beverage is safe without side effects, is convenient for consumption, and has relative good market application prospects.

The present invention discloses a maca flour and a preparation method thereof. The maca flour is characterized by being prepared from the following raw materials in parts by weight: wheat 500-510 parts, xanthan gum 3.5-4 parts, maca 20-22 parts, sweet potatoes 25-30 parts, sesame oil 7-8 parts, laminaria japonica powder 10-11 parts, fallopia multiflora 4-5 parts, polygonatum sibiricum 3-4 parts, polygonatum odoratum 5-6 parts, poria cocos 2-3 parts and epimedium brevicornum 4-5 parts. The added xanthan gum can increase the viscosity of the flour and enable the flour to be suitable for preparing noodles, and thus the prepared noodles are tougher, boil-resisting, resilient and chewy. At the same time, parts of the wheat in the raw material sprout and are ground into powder, which can increase gamma-aminobutyric acid content of the flour, and the microwave treatment of the sprouted wheat can reduce the activity of alpha-amylase, and avoid the influence of the wheat flour quality due to the sprouting process. In addition, the added maca and sweet potatoes in the flour can remove human body free radicals, and the matched traditional Chinese medicines can prevent aging.